Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)

NCT02666391 is registered in ClinicalTrials.gov with South China Research Center for Stem Cell and Regenerative Medicine as lead sponsor.

NCT NCT02666391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02666391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)
Lead sponsor
South China Research Center for Stem Cell and Regenerative Medicine
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2016
Completion date
December 31, 2017
Enrollment
64 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, ischemic cardiomyopathy, myocardial infarction